USD 10.8
(0.0%)
Breakdown | 2023 | 2022 | 2021 |
---|---|---|---|
Revenue | - | - | - |
Cost of Revenue | - | - | - |
Gross Profit | - | - | - |
Operating Expenses | 999.14 Thousand | 1.12 Million | 390.58 |
Selling, General and Administrative Expenses | 999.14 Thousand | 923.31 Thousand | 178.20 |
Research and Development Expenses | - | - | - |
Other Expenses | - | 200 Thousand | - |
Cost and Expenses | 999.14 Thousand | 1.12 Million | 390.58 |
Operating Income | -1.19 Million | -1.12 Million | -390.58 |
Interest Expense | - | - | - |
Income Tax Expense | -1.18 Million | 858.72 Thousand | 5.43 |
Earnings before Tax | 1.51 Million | 3.28 Million | -385.15 |
Net Income | 2.69 Million | 2.42 Million | -385.15 |
Earnings Per Share Basic | 0.20 | 0.08 | - |
Earnings Per Share Diluted | 0.20 | 0.08 | - |
Weighted Average Shares Outstanding | 13.81 Million | 31.35 Million | 41.8 Million |
Weighted Average Shares Outstanding (Diluted) | 13.81 Million | 31.35 Million | 41.8 Million |
Gross Margin | - | - | - |
EBIT Margin | - | - | - |
Profit Margin | - | - | - |
EBITDA | -1.19 Million | -5.53 Million | 5.43 |
Earnings Before Tax Margin | - | - | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 332.18 Thousand | 410.46 Thousand | 999.14 Thousand | 326.71 Thousand | 294.64 Thousand | 321.9 Thousand |
Selling, General and Administrative Expenses | 333.59 Thousand | 357.76 Thousand | - | 276.71 Thousand | 244.64 Thousand | 271.9 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -1411.00 | - | - | -50.4 Thousand | - | - |
Cost and Expenses | 332.18 Thousand | 410.46 Thousand | 999.14 Thousand | 326.71 Thousand | 294.64 Thousand | 321.9 Thousand |
Operating Income | -332.18 Thousand | -410.46 Thousand | -1.19 Million | -326.71 Thousand | -294.64 Thousand | -321.9 Thousand |
Interest Expense | - | - | - | 3.28 Million | - | - |
Income Tax Expense | 48.59 Thousand | 43.98 Thousand | -1.18 Million | 85.81 Thousand | 108.38 Thousand | 307.63 Thousand |
Earnings before Tax | -174.2 Thousand | -396 Thousand | 1.51 Million | -2.86 Million | 181.48 Thousand | 1.16 Million |
Net Income | -222.79 Thousand | -439.98 Thousand | 2.69 Million | -2.94 Million | 73.09 Thousand | 855.37 Thousand |
Earnings Per Share Basic | -0.02 | -0.03 | - | -0.21 | 0.00 | 0.03 |
Earnings Per Share Diluted | -0.02 | -0.03 | - | -0.21 | 0.00 | 0.03 |
Weighted Average Shares Outstanding | 13.24 Million | 13.78 Million | 13.81 Million | 13.81 Million | 15.95 Million | 11.8 Million |
Weighted Average Shares Outstanding (Diluted) | 13.24 Million | 13.78 Million | 13.81 Million | 13.81 Million | 15.95 Million | 11.8 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -488.02 Thousand | -420.3 Thousand | - | 2.2 Million | -770.69 Thousand | -1.8 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
PARNAXLAB
EQC-PD
GELGF
600170
OLVI
002403